Emletra Tablets – Generic Kaletra

Emletra Tablets – Generic Kaletra

Emletra Tablets – Generic Kaletra is an antiretroviral medication used for the treatment of HIV-1 infection. It contains a combination of lopinavir and ritonavir, which work together to suppress viral replication and improve immune system function. This medicine is commonly used as part of combination antiretroviral therapy (ART) to help maintain a low viral load and prevent disease progression. In treatment plans, alternatives such as Inbec Tablets – Triumeq and Spegra Tablets may also be used depending on patient condition and resistance patterns.

Mechanism of Action

Protease Inhibitor Combination

• Lopinavir inhibits the HIV protease enzyme, preventing viral maturation.
• Ritonavir boosts the effectiveness of lopinavir by slowing its breakdown in the body.

Viral Suppression

This dual action helps reduce the amount of HIV in the body and supports immune function. For clinical insights, refer to World Health Organization (WHO) and for safety guidance, consult Mayo Clinic – Lopinavir/Ritonavir Information.

Medical Uses

Emletra Tablets – Generic Kaletra is used for:

• HIV-1 infection treatment
• Viral load suppression
• Combination antiretroviral therapy (ART)
• Prevention of HIV progression

It is widely used in both adults and pediatric patients.

Dosage and Administration

Emletra Tablets are taken orally, usually once or twice daily as prescribed by a healthcare provider. It should be taken with food for better absorption. Consistent daily use is important to maintain viral suppression. In clinical practice, Inbec Tablets – Triumeq and Spegra Tablets may be used as alternative ART regimens.

Clinical Effectiveness

Clinical studies show that lopinavir/ritonavir-based regimens effectively reduce viral load and improve immune response when used consistently as part of combination therapy.

Safety and Side Effects

Common Side Effects

• Diarrhea
• Nausea
• Headache
• Fatigue

Serious Risks

• Liver dysfunction
• Pancreatitis (rare)
• Increased cholesterol and triglycerides

Regular monitoring is recommended. For more details, refer to Mayo Clinic – Lopinavir/Ritonavir Information.

Contraindications and Precautions

Emletra Tablets should be used with caution in:

• Patients with liver disease
• Individuals with pancreatitis history
• Patients taking multiple medications (due to interactions)

Medical supervision is essential.

Drug Interactions

This medication has multiple drug interactions, especially with drugs metabolized by the liver enzyme CYP3A. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to World Health Organization (WHO).

FAQs